ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Sanofi’s RSV treatment nirsevimab awarded PIM pharmatimes
January 22, 2021Sanofi’s nirsevimab has been awarded a Promising Innovative Medicine (PIM) designation by the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK for the prevention of respiratory syncytial virus (RSV) associated lower respiratory ... -
Nirsevimab gets Promising Innovative Medicine Designation from MHRA expresspharma
January 19, 2021Nirsevimab is an innovative monoclonal antibody in Phase 2 and Phase 3 trials for the prevention of respiratory syncytial virus (RSV) infections in healthy late preterm, term and high-risk infants. -
Akcea’s rare lipid disorder drug wins PIM status
pharmatimes
October 11, 2017Akcea Therapeutics’s volanesorsen has been granted a Promising Innovative Medicine designation by the Medicines and Healthcare products Regulatory Agency for the treatment of familial chylomicronaemia syndrome , a rare genetic lipid disorder.
Pharma Sources Insight January 2025
